Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals
₹627.15
4.85 (0.78%)
High VOLATILITY
As on 10 Jul 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹12.27K Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
49.8
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Pharmaceuticals
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹259.5+141.7%
52W High₹633.3-1.0%
Current Price
₹627.15
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹501.72
Upper Circuit₹752.58
Reference Price
₹627.15
Investment Checklist
Ascending Channel on 1D — target ₹645.96
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
Composite score 54.2 (BUY) with 89.8% confidence
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price above SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-07-10
Confidence
90%
Trend
BULLISH
BULLISH
Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
EMA20
580.92
EMA50
528.53
EMA200
434.75
Price Action
MIXED
NEUTRAL
Higher Highs7
Higher Lows5
Lower Highs2
Lower Lows4
Support & Resistance Levels
Resistance (Above)
No recent resistance detected
Support (Below)
₹615.00
₹581.00
₹529.80
₹524.05
₹473.72
Volume Analysis
TrendINCREASING
Change+11.00%
Unusual VolumeNo
Stop Loss Levels
Fixed Risk
1% Risk₹620.88
3% Risk₹608.34
5% Risk₹595.79
7% Risk (Custom)
₹583.25Technical Levels
1x ATR (Volatility)₹600.71
2x ATR (Swing)₹574.27
3x ATR (Trend)₹547.83
Immediate Support₹615.00
Moving Averages
EMA 9 (Short-term)₹602.76
EMA 20 (Medium-term)₹580.92
EMA 50 (Trend)₹528.53
EMA 200 (Long-term)₹434.75
Financials
Financial Analysis
| Metric | Mar '25 | Jun '25 | Sep '25 | Dec '25 |
|---|---|---|---|---|
| Revenue | ₹330.8 Cr | ₹321.5 Cr | ₹370 Cr | ₹409.7 Cr |
| Net Profit | ₹14.5 Cr | ₹46.9 Cr | ₹44.1 Cr | ₹44.6 Cr |
| EPS | — | ₹2.40 | ₹1.13 | ₹2.36 |
| Operating Profit | ₹58.6 Cr | ₹97.3 Cr | ₹109.9 Cr | ₹101.9 Cr |
ROE
3.31%
ROCE
6.71%
Debt/Equity
0.25
Current Ratio
1.46
OPM
24.87%
NPM
10.88%
Peer Comparison
PharmaceuticalsPeer Comparison
Symbol | Name | Price | Change | P/E Ratio | Market Cap |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | ₹1,935.50 | -0.17% | 40.2 | ₹4.64L Cr large Cap | |
| Divi's Laboratories Limited | ₹6,836.00 | +0.34% | 70.4 | ₹1.81L Cr large Cap | |
| Torrent Pharmaceuticals Limited | ₹4,901.50 | +0.07% | 77.5 | ₹1.66L Cr large Cap | |
| Cipla Limited | ₹1,439.40 | -0.13% | 30.1 | ₹1.16L Cr large Cap | |
| Zydus Lifesciences Limited | ₹1,150.80 | -0.71% | 23.0 | ₹1.16L Cr large Cap | |
| Lupin Limited | ₹2,496.30 | -0.28% | 21.4 | ₹1.14L Cr mid Cap | |
| Mankind Pharma Limited | ₹2,525.10 | -0.27% | 54.3 | ₹1.04L Cr mid Cap | |
| Dr. Reddy's Laboratories Limited | ₹1,244.30 | -1.99% | 25.6 | ₹1.04L Cr large Cap | |
| Aurobindo Pharma Limited | ₹1,564.70 | -1.43% | 26.1 | ₹90.88K Cr mid Cap | |
| Laurus Labs Limited | ₹1,537.80 | +2.02% | 91.5 | ₹83.02K Cr mid Cap | |
| Shilpa Medicare Limited | ₹627.15 | +0.78% | 49.8 | ₹12.27K Cr small Cap |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Corporate Actions
Recent actions
| Ex Date | Purpose | Type |
|---|---|---|
| 03 Oct 2025 | Bonus 1:1 | BONUS |
| 17 Sept 2025 | Dividend - Re 1 Per Share | DIVIDEND |
| 06 Sept 2024 | Annual General Meeting | AGM |
| 22 Sept 2023 | Annual General Meeting | AGM |
| 19 Sept 2022 | Annual General Meeting/Dividend - Rs 1.10 Per Share | AGM |
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for SHILPAMED
View All
positive
Google News - India Markets 10d ago
BPCL Boosts Petrochemical Business Footprint | Shilpa Medicare Partners Orion for Nivolumab | Top Buzzing Stocks Today - Equitymaster
BPCL Boosts Petrochemical Business Footprint | Shilpa Medicare Partners Orion for Nivolumab | Top Buzzing Stocks TodayEquitymaster
BPCLSHILPAMEDHealthcareOil Gas & Consumable Fuels
positive
Business Standard - Markets 11d ago
Shilpa Medicare jumps 6% to hit 52-week high; check what's fuelling gains
Shilpa Medicare has announced that its wholly owned subsidiary, Shilpa Biologicals, has entered into a co-development and supply agreement with Orion Corporation
SHILPAMEDHealthcare
negative
CNBC TV18 - Markets 11d ago
Shilpa Medicare shares gain 5% after arm partners with Orion Corp for cancer treatment drug
Shilpa Medicare shares rose over 5% after its subsidiary partnered with Orion to co-develop and supply a nivolumab biosimilar for Europe. Orion will market the drug, while the Shilpa Medicare arm handles manufacturing. The deal aims to expand access to affordable cancer therapy.
AFFORDABLESHILPAMEDCapital GoodsHealthcare